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DDR1-deficient mice show localized subepithelial GBM thick-
ening with focal loss of slit diaphragms and proteinuria.
Background. Type IV collagen in basement membranes is a
ligand for the receptor tyrosine kinase discoidin domain recep-
tor 1 (DDR1). DDR1 is expressed in renal cells and regulates
cell adhesion and proliferation ex vivo. The interaction between
type IV collagen and cell surface receptors is believed impor-
tant for normal renal function as well as significant in chronic
renal diseases and we therefore analyzed mice with a targeted
deletion of DDR1.
Methods. Homozygous DDR1 knockout mice were com-
pared to heterozygous and wild-type animals. The quantita-
tive and qualitative amount of proteinuria was measured by
urine-microelectrophoresis. Structural changes of the kidneys
were determined by immunohistochemistry, light microscopy,
and electron microscopy.
Results. Compared to heterozygous littermates, adult DDR1
knockout mice showed a selective middle- to high-molecular
proteinuria of up to 0.3 g/L and urinary acanthocytes. There
was no evidence of uremia with no change in serum urea in
the first 9 months of age. Little apparent change in renal mor-
phology was detected using light microscopy. However, electron
microscopy showed a localized, subepithelial, mushroom-like
isodense thickening of the glomerular basement membrane
(GBM). Within these areas, a focal loss of the podocytic slit
diaphragms occurred.
Conclusion. The loss of cell-matrix communication in DDR1-
deficient podocytes appears to result in excess synthesis of base-
ment membrane proteins leading to disturbed anchorage of foot
processes and disruption of the slit diaphragm. Our data suggest
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that the interaction between type IV collagen and DDR1 plays
an important role in maintaining the structural integrity of the
GBM.
Basement membranes are responsible for tissue com-
partmentalization and maintenance of organ architec-
ture. Additionally, they are important barriers during the
filtration of macromolecules. This latter function is par-
ticularly apparent in the glomerular basement membrane
(GBM), which serves as filtration barrier between the lu-
men of the glomerular capillaries and Bowman’s space
within the renal glomerulus. The GBM is a fusion prod-
uct of two basement membranes made by endothelial
and specialized epithelial cells, called podocytes. Fenes-
trations within the endothelial cell layer allow direct ac-
cess of plasma proteins to the GBM. The GBM acts as
the primary filtration unit and retains any protein with
the size of albumin or greater. The intricate network
of interdigitating primary and secondary foot processes
reaching out from the podocytes builds the second fil-
tration unit. The foot processes are connected by a slit
diaphragm of approximately 40 nm width. Mainly based
on electron microscopy work, Rodewald and Karnovsky
[1] (1974) suggested a highly ordered zipper-like structure
for the slit diaphragm. Since this early work on the struc-
ture of the GBM filtration unit, much has been learned
about the molecules that generate its unique permselec-
tivity and mechanical stability. Several proteins have been
identified specifically expressed at the cell-cell junctions
forming the slit diaphragm. Nephrin, a transmembrane
glycoprotein, together with Neph1, P-cadherin, and
podocin, have been recognized as central organizers of
the slit architecture. Attached to the cytoplasmic tail of
nephrin is CD2-associated protein (CD2AP), which acts
as linkage to the actin cytoskeleton [2].
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A primary constituent of the GBM is the network of
type IV collagen, long molecules with interrupted triple-
helical stretches, which aggregate into a highly ordered
mesh through their N-terminal and C-terminal globular
domains. Type IV collagen exists as a family of triple he-
lical protomers assembled from three a chains. In hu-
mans, six genetically distinct a chains, designated a1(IV)
to a6(IV), have been identified, and each is encoded
by a separate gene designated COL4A1 to COL4A6,
respectively [3]. While the immature GBM consists
of a1(IV)2a2(IV) molecules, a3(IV)a4(IV)a5(IV) het-
erotrimers are found in the mature GBM [4, 5]. In
addition, type IV collagen is engaged in a variety of
protein-protein interactions with other GBM compo-
nents, including laminins, proteoglycans, nidogen, as well
as in cell attachment via a1b 1 integrin [6]. Genetic mu-
tations in any of the mature type IV collagen chains re-
sult in Alport syndrome characterized by hematuria and
proteinuria, progressive renal failure, sensorineural deaf-
ness, and typical ocular changes [7]. Characteristic ultra-
structural changes found in Alport syndrome relate to the
GBM, the architecture of which is severely disturbed dur-
ing the course of the disease. The GBM appears thin in
early stages and later tends to thicken, to split and to be-
come lamellated. Alport syndrome is now understood as
a disorder of specific type IV collagen chains, with renal
disease arising from altered basement membrane com-
position. However, the chain of molecular events leading
from gene mutation in a type IV collagen gene to pro-
gressive glomerular scarring and loss of kidney function
has yet to be determined. One step in the sequence is
an altered cell-matrix interaction via type IV collagen re-
ceptors such as integrins [8]. The possible involvement of
discoidin domain receptor 1 (DDR1) as alternative type
IV collagen receptor in normal glomerular function and
in GBM-based diseases (such as Alport syndrome) has
not been previously addressed.
DDR1 and DDR2 are receptor tyrosine kinases, and
are distinguished by a discoidin module in their extracel-
lular domain, a homology region originally identified in
the protein discoidin I from Dictyostelium discoideum [9,
10]. A unique feature of DDR1 and DDR2 is the fact
that both receptors have collagens as their cognate lig-
ands. DDR1 activation is achieved by all collagens tested
so far, including those of the basement membrane, such as
type IV collagen, whereas DDR2 is only activated by fib-
rillar collagens [11, 12]. In adherent cells, maximal DDR1
phosphorylation is reached after several hours of colla-
gen stimulation, whereas this takes place somewhat faster
in suspension cultures [13]. Messenger RNA expression
of DDR1 is predominantly seen in epithelial cells, partic-
ularly from kidney, lung, gastrointestinal tract, and brain;
however, very little is known about the precise cellular
distribution of the DDR1 protein [9].
Deletion of DDR1 in the mouse germ line resulted
in viable animals that are significantly smaller than their
littermates [14]. Female DDR1 null mice show defects
in blastocyst implantation and mammary gland develop-
ment. Furthermore, in primary vascular smooth muscle
cells cultivated from DDR1-null mice, decreased prolif-
eration, collagen-attachment, and migration have been
observed [15]. DDR1 was previously shown to control
growth and adhesion of renal mesangial cells [16]. In
the present study, we analyzed the kidney phenotype of
DDR1 knockout mice in order to address the relevance
of DDR1 in normal renal function and chronic renal dis-
ease. We show that mice lacking DDR1 develop protein-
uria due to an altered GBM morphology and partial loss
of slit diaphragms but do not progress to chronic renal
disease.
METHODS
Knockout mice
The generation and genotyping of DDR1 null mice has
been described earlier [14]. All mice used were from a
mixed 129/Sv and ICR background and free of pathogens.
Control mice were wild-type or heterozygous littermates
of DDR1 knockout mice. For this study, a total of 35
DDR1 null mice were used from both genders at dif-
ferent age ranging from 3 to 9 months. Homozygous
COL4A3 knockout mice were obtained by crossbreeding
heterozygous animals (Jackson Immunoresearch Labo-
ratories, Westgrove, PA, USA). All animal procedures
were in accordance with the Declaration of Helsinki and
the Guide for the Care and Use of Laboratory Animals
(NIH).
Clinical biochemical analysis
Urine was collected by housing mice in metabolic cages
and analyzed by high power field microscopy and micro-
electrophoresis. Ten microliters of urine were used for mi-
croelectrophoresis on gradient polyacrylamide gels that
were subsequently stained by Coomassie blue and ana-
lyzed by densitometry. As previously described, a semi-
quantitative technique was used to qualify (by molecular
weight from 10 to 1000 kD) and quantify proteinuria [17].
Serum urea concentrations were determined with a Hi-
tachi 917 Automatic Analyzer (Boehringer Mannheim,
Mannheim, Germany) using 250 to 1000 lL samples of
heparinized blood.
Light and electron microscopy
Both studies were performed on epoxy-embedded tis-
sue. Mice were transcardially perfused with a solution of
2% paraformaldehyde and 2% glutaraldehyde buffered
with 0.1 mol/L sodium cacodylate, pH 7.3. Kidneys were
immediately removed and immersion-fixed. For epoxy
resin embedding, external renal cortex was washed with
0.1 mol/L sodium cacodylate and postfixed in 1% os-
mium tetroxide. Tissue was dehydrated in graded ethanol
including an uranylic acetate en bloc staining step in
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70% ethanol. Before infiltration with Araldite Cy 212
epoxy resin (Serva, Heidelberg, Germany), propylene
oxide was used as intermedium. Tissue blocks were
cured at 60◦C for 60 hours. Semithin (500 nm) and
thin (60 nm) sections were taken on a Reichert Ul-
tracut UCT ultramicrotome (Leica, Vienna, Austria).
Semithin sections of kidney cortex were oxidized for
10 minutes in freshly prepared 1% aqueous periodic acid
and then processed to detect argyrophilia affinity of base-
ment membranes employing Jones’ method [18]. Thin
sections were stained with uranyl acetate and lead cit-
rate. A Zeiss Axiophot microscope for light microscopy
and a Zeiss EM 902 microscope for electron microscopy
were used for histologic documentation (Carl Zeiss, Inc.,
Oberkochen, Germany).
For GBM thickness and area quantification, a total of
ten electron micrographs of glomeruli taken from two
different animals per genotype were subjected to image
analysis using analySIS docu3.2 software (Soft Imaging
Systems, Mu¨nster, Germany). Student t test was used for
statistical analysis.
Immunohistochemistry of tissue sections
Samples of renal cortex were embedded in OCT and
snap-frozen in liquid nitrogen. Cryosections (5 lm) were
stained with the rat monoclonal antibodies H11, H22,
H31, H44, H52/H53 to the human a1(IV) to a5(IV)
collagen chains, and B66 to the bovine a6(IV) chain.
The specificity and reactive epitopes of these anti-
bodies have previously been described [19–21]. Unless
stated otherwise, all immunologic reagents were obtained
from Vector Laboratories (Burlingame, CA, USA). For
collagen staining, sections were fixed in acetone for
10 minutes at 4◦C, washed in phosphate-buffered saline
(PBS), and incubated for 10 minutes with a 100 mmol/L
KCl solution (pH 1.5, HCl) to expose epitopes. Slides
were blocked with 1.5% rabbit serum for 45 minutes,
and then incubated with the rat monoclonal antibodies
(1:100 dilution) in blocking reagent for 90 minutes. Af-
ter washing in PBS, sections were incubated for 1 hour
with a biotinylated rabbit antirat antibody (1:200 dilu-
tion), then a peroxidase-conjugated avidin-biotin com-
plex (ABC) for 30 minutes, with a 5-minute incubation
in 0.05% diaminobenzidine in 50 mmol/L Tris HCl, pH
7.6, as a chromagen. Sections were counterstained with
hematoxylin. This protocol was modified for use with
a polyclonal rabbit antimouse CD2AP antibody (a gift
from Dr Andrey Shaw, Washington University, St. Louis,
MO, USA). For these studies, cryosections were fixed
in 2% paraformaldehyde in PBS for 6 minutes at 4◦C
and then blocked, without antigenic retrieval, in 1.5%
goat serum. Sections were incubated with the CD2AP
antibody (1:1000 dilution) for 1 hour, followed by a bi-
otinylated goat antirabbit antibody (1:200 dilution) for
30 minutes, which was detected using the ABC technique
above. A polyclonal rabbit antihuman podocin antibody
(clone P35) (a gift from Dr Corinne Antignac, Institut
National de la Sante´ et de la Recherche Me´dicale, Paris,
France) was used for immunoperoxidase staining ac-
cording to previously published methods [22]. Polyclonal
rabbit anti-mouse DDR1 antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) were used for im-
munoperoxidase staining according to previously pub-
lished methods [17].
Immunohistochemistry of tissue culture cells
Human immortalized podocytes were grown on cover
slips coated with type I collagen (0.1 mg/mL) for 1 week
and then fixed in cold acetone for 5 minutes. Cover slips
were incubated with avidin-biotin blocking reagent (Vec-
tor Laboratories) for 30 minutes, then with 1.5% blocking
serum for 60 minutes. The primary antibody was a poly-
clonal rabbit antihuman DDR1 (1:25 dilution) (Santa
Cruz Biotechnology) applied for 60 minutes, followed
by an antirabbit biotinylated secondary antibody (1:200
dilution) (Vector Laboratories) for 60 minutes, then flu-
orescein isothiocyanate (FITC)-streptavidin (1:50 dilu-
tion) (Vector Laboratories) for 60 minutes.
RESULTS
DDR1−/− mice show proteinuria
DDR1−/− mice showed no apparent sign of abnormal
renal function on daily routine tests. Signs such as edema,
weight loss, or abnormal fluid intake were absent. Up to
9 months of age, serum urea was within the normal range
(44 ± 6 mmol/L). Microscopy of urine from 6-month-
old DDR1−/− mice revealed one to five erythrocytes
per visual field and zero to two acanthocytes, while urine
from age-matched heterozygous mice showed no cellu-
lar constituents. Microelectrophoresis of urine from con-
trol mice showed a single peak of prealbumin at 50 kD
and only small amounts (less than 50 mg/L) of albumin
(66 kD), haptoglobin, and immunoglobulins (Fig. 1A).
In contrast, urine from DDR1−/− mice showed several
peaks of high-molecular-weight proteins, including large
amounts of albumin, transferrin, haptoglobin, and im-
munoglobulins (IgA, IgG) (70 to 150 kD) (Fig. 1B). We
found a protein concentration of up to 0.3 g/L in the urine
of DDR1 knockout mice, compared to a normal concen-
tration of less than 0.05 g/L in control mice. We did not
find any worsening of the proteinuria or increased serum
urea in older mice. To investigate potential causes for
this loss of high-molecular-weight proteins in DDR1−/−
mice, we performed detailed histologic and electron mi-
croscopy studies of the renal tissue.
Light microscopy and immunohistochemistry
reveals only minor abnormalities in kidney structure
or architecture
Light microscopy of semithin kidney sections showed
normal distal and proximal tubules and no indication of
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Fig. 1. Microelectrophoresis of urine from
wild-type (left) and discoidin domain recep-
tor 1 (DDR1) knockout mice (right). DDR1
null mice showed a selective proteinuria of up
to 0.3 g/L (N = 8).
A
+/–
C
–/–
E
–/–
F
–/–
D
–/–
B
–/–
Fig. 2. Morphology of renal tissue from control heterozygous (+/−) (A) and discoidin domain receptor 1 (DDR1) null (−/−) (B to F) mice. A
mild increase of intracellular vacuoles was noticed in the DDR1−/− mice compared to control mice [magnification 400× (A to D), 1000× (E and
F)].
increased tubulointerstitial matrix deposition or cell inva-
sion (Fig. 2). Compared to heterozygous mice (Fig. 2A),
a modest increase of intracellular vacuoles was noticed in
the tubular epithelial cells of DDR1−/− mice, in keep-
ing with increased intratubular protein load and protein
reabsorption (Fig. 2B to F). However, no glomeruloscle-
rosis, tubulointerstitial fibrosis or loss of nephrons was
detected in knockout tissue.
We verified the expression of DDR1 in the glomerulus
by immunostaining of tissue sections from 4-month-old
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A B
Fig. 3. Immunodetection of discoidin do-
main receptor 1 (DDR1). (A) Section of wild-
type renal tissue revealed specific expression
of DDR1 in podocytes (magnification 630×).
(B) Immortalized podocytic cells showed cy-
toplasmic expression of DDR1 (magnification
800×).
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wild-type mice and found specific DDR1 expression in
podocytes (Fig. 3A). Furthermore, we utilized a condi-
tionally immortalized podocyte cell line to verify DDR1
expression ex vivo (Fig. 3B). Next, we used immunohis-
tochemistry to analyze the expression of proteins rele-
vant for podocyte function, such as podocin and CD2AP.
We found that both marker proteins were expressed at
equal levels in mutant and control tissue indicating that
the proteinuria observed in DDR1 null mice is probably
not due to a significant loss of podocytes (Fig. 4). To eval-
uate the composition of the GBM in DDR1 knockout
mice, kidneys from 6-month-old mice were stained using
chain-specific antibodies to type IV collagen. We found
that all isoforms, a1(IV) to a6(IV), were expressed at
comparable levels in DDR1 null and heterozygous mice
(Fig. 4, and data not shown). The distribution of these
proteins in the glomerulus was as expected: the a3(IV)
to a5(IV) chains were localized predominantly in the
GBM, whereas the a6(IV) chain was found in Bowman’s
capsule.
Electron microscopy of DDR1 null renal tissue shows a
subepithelial localized, isodense thickening of the GBM
Electron microscopy of the glomeruli from wild-type
mice showed a thin uniform GBM throughout the
whole capillary loop with normal-appearing podocytes,
endothelial cells, and mesangial regions (Fig. 5A and J).
In contrast, all sections taken from DDR1 null tissue
demonstrated localized thickenings of the GBM (Fig. 5B
to I and K). These mushroom-like thickenings of the
GBM were located subepithelial and appeared in most
cases isodense at higher magnifications (Fig. 5G and K).
Multiple images are presented in Figure 5 to illustrate
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 4. Immunohistologic staining for podocin (first row), CD2AP
(second row), or various type IV collagen a-chain (lower rows). Podocin
and CD2AP are expressed to similar levels in 4-month-old discoidin
domain receptor 1 (DDR1) −/− and DDR1+/− mice. All six a chains
of type IV collagen are expressed in DDR1 null tissue (magnification
400×).
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Fig. 6. Reconstitution of an entire glomerulus using multiple electron micrographs. The random distribution of isodense bulges within the glomeru-
lar basement membrane (GBM) is apparent [magnification 3000× (overview) and 12,000× (inserts)]. Arrow is cleared zone in GBM.
the peculiar appearance of these morphologic changes.
Bulges were found in all knockout mice tested (age 3 to 9
months) and no increase over age was observed. A recon-
stitution of several electron microscopy images indicated
that the localized thickening was independent from the
diameter of mesangial space opening (Fig. 6). The altered
morphology of podocytes next to the areas of localized
thickening was marked by asterisks in Figures 5E and F.
To further assess these localized bulges within the GBM,
we correlated the thickened areas versus the total GBM
surface semiquantitatively on several different sections.
We found 3.4% (P < 0.05) of the GBM affected in DDR1
knockout mice, whereas only 1.2% of the GBM was al-
tered in heterozygous DDR1 mice and none in wild-type
controls. Additionally, we measured the thickness of the
GBM in the unaffected region. We found a slight differ-
ence between control GBM (124 nm) and DDR1 null
(138 nm), which, however, was not statistically signifi-
cant. In only very few of the bulges, we observed cleared
areas within the GBM (Figs. 5F and 6, arrows). Cleared
zones in the GBM are much more commonly observed in
COL4A3 knockout mice, an animal model for human Al-
port syndrome [23, 24]. In contrast to our findings from
Fig. 5. Ultrastructural analysis of the glomerular basement membrane (GBM) in discoidin domain receptor 1 (DDR1) null mice. Electron mi-
croscopy showed a localized, mushroom-like isodense thickening of the GBM. Compared to the GBM in wild-type mice (A and J), DDR1 null
animals showed characteristic subepithelial bulges, as indicated by arrows (B to I and K). In comparison, splitting and thickening of the GBM is
found in COL4A3−/− mice (L). Tissues from several animals with both genders [males (A to I) and female (J and K)] at age 3 to 9 months were
analyzed (magnification 3000× (A), 7000 to 12,000× (B to K), and 30,000× (L). Abbreviations are: P, podocyte foot processes; C, capillary lumen;
∗, activated podocytes; arrows, cleared zones in GBM.
the DDR1 null mice, the GBM from COL4A3 knock-
out mice shows extensive splitting and thickening of the
GBM due to increased deposition of fibrillar collagens
(Fig. 5L) [17, 23, 24].
Within the areas of localized thickening of the GBM, a
partial loss of the slit diaphragm was documented
Higher magnification of the bulge-like structures
within the GBM of DDR1 null mice revealed a focal
loss of the slit diaphragm in-between the podocyte foot-
processes (Fig. 7). While the slit diaphragm was visual-
ized as a distinctive intercellular junction in more than
98% of the GBM in wild-type or nonthickened areas in
DDR1 null mice, it was absent in a significant number of
podocyte foot process junctions adjacent to the bulged
GBM in knockout mice. Interestingly, these defects were
mainly localized to the tips of the bulges, which are fur-
thest away from the endothelium.
DISCUSSION
Our previous work showed that DDR1 controls pro-
liferation and adhesion of primary renal mesangial cells
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Slit diaphragm
GBM
P = podocyte foot process
E = endothelial cell
GBM = glomerular basement membrane
Fig. 7. Focal loss of the slit diaphragm in discoidin domain receptor 1 (DDR1) null tissue. High-resolution electron microscopy revealed selective
loss of slit diaphragms adjacent to glomerular basement membrane (GBM) protrusions (left) as highlighted in the drawing (right). Abbreviations
are: P, podocyte foot processes; E, endothelial cells (magnification 80,000×).
in vitro [16]. In the present study, we investigated the
functional role of DDR1 in vivo using knockout mice.
Immunohistochemical analysis revealed a prominent
presence of DDR1 in the glomerulus, particularly in
podocytes, which is indicative of a vital role during nor-
mal renal function. Indeed, in DDR1 null mice, urine
analyses showed acanthocytes and selective proteinuria
of high-molecular-weight proteins, indicating significant
defects within the filtration barrier of the GBM or the
glomerulus. Electron micrographs revealed morphologic
alterations of the GBM, specifically a localized subep-
ithelial bulging of the GBM in DDR1 null mice, while
heterozygous mice had normal basement membrane ar-
chitecture. The abnormal bulges protruding from the
GBM were mostly isodense in the electron micrographs,
indicating a composition similar or identical with nor-
mal GBM. However, immunoelectron microscopy stud-
ies or a biochemical analysis will be necessary to precisely
define the molecular composition of the bulges. The
reconstruction of electron microscopy images from an
entire glomerulus showed that the protrusions appear
randomly throughout the GBM. We propose that the
structures observed here as bulges in cross-sections may
actually resemble creases within the GBM in a three-
dimensional tissue environment; however, further experi-
mental work by scanning electron microscopy of acellular
glomeruli will be necessary to clearly define their unusual
appearance.
Immunohistochemical studies showed a similar distri-
bution of all six chains of type IV collagen in DDR1 null
and wild-type mice. Within the areas of localized thick-
ening, a loss of slit diaphragm was noted in a significant
number of podocyte foot processes. In contrast, the slit
diaphragm was detected in nearly all areas with a normal
width of the GBM in the DDR1 null mice as well as in
wild-type controls. Potentially, the loss of DDR1 signal-
ing in podocytes leads to an altered interaction between
podocytes and the GBM resulting a localized basement
membrane overproduction. Potentially, transmembrane
signaling by DDR1 in healthy podocytes may be nec-
essary to maintain transcription of nephrin or nephrin-
associated proteins such as synaptopodin and thereby
ensuring an intact slit diaphragm. Conversely, in mutant
podocytes, the lack of DDR1 signals would result in di-
minished expression of these proteins leading to a partial
loss of slit diaphragms. These defects in protein expres-
sion may potentially be beyond the resolution of light
microscopy since all bulges are focal. However, to draw
more definitive conclusions, additional work is required,
including the subcellular localization of DDR1 in the con-
text with other slit diaphragm-associated proteins.
The molecular composition of the slit diaphragm has
remained enigmatic until recently. Following the anal-
ysis of the genomic locus for a rare disorder, termed
congenital nephrotic syndrome of the Finnish-type, the
transdiaphragm protein nephrin was identified and local-
ized in the slit diaphragm. Inactivation of nephrin in the
mouse caused massive proteinuria confirming its central
role in glomerular filtration [25]. The extracellular do-
main of nephrin functions as cell adhesion molecule by
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engaging homophilic interaction at cell-cell junctions and
heterophilic interactions with nephrin-like molecules,
such as Neph1 [26, 27]. The cytoplasmic domain of
nephrin clusters a complex of proteins including podocin
and CD2AP, which link the diaphragm proximal region
with the actin filament [28, 29]. However, little is know
about the in vivo dynamics of this complex in establish-
ing and maintaining the integrity of the slit diaphragm [2].
Although the absence of DDR1 does not affect the over-
all expression of either podocin or CD2AP, there could be
localized changes in expression, which would not be ap-
parent at the light microscopy level. Alternatively, DDR1
could contribute indirectly to the nephrin-complex within
the slit diaphragm by regulating the phosphorylation
and/or activity of downstream binding partners.
According to our current model, the lack of DDR1
leads to a punctuated disintegration of some slit
diaphragm complexes. The localized absence of this fil-
tration unit results in increased flux of unfiltered pro-
teins and cellular components through these openings
resulting in proteinuria. Due to the increased mechan-
ical pressure at these sites, the GBM responds with a lo-
calized swelling leading to the bulge-like protrusions of
the GBM. Alternatively, localized mechanical stress in a
GBM with intact slit diaphragms could first cause the ob-
served thickening, which then alters the gap between the
foot-processes in a way that inhibits the normal zipper-
like binding of nephrin necessary to sustain the architec-
ture of the slit diaphragm. In any case, it remains to be
fully determined why the observed lesions have such a
peculiar, focal nature.
To our knowledge, similar ultrastructural alterations
to those found in the GBM of DDR1 null mice have not
been reported from human renal disease. However, it is
of note that ddY mice, a line first characterized some
years ago in Japan, display an ultrastructural GBM mor-
phology very similar to DDR1 knockout mice [30]. Start-
ing at 6 months of age, ddY mice develop spontaneous
glomerular IgA deposition and have therefore been used
as animal model for IgA nephritis [31, 32]. Further exper-
imental work will investigate whether DDR1 is involved
in IgA-induced nephropathy.
Our current data support an important function of
DDR1 not only in proliferation and adhesion of mesan-
gial cells, but also in maintaining the integrity of the slit
diaphragm of the podocyte and GBM architecture. Fur-
ther investigations are needed to sort out the sequence of
events that brings about the changes we have observed
in different renal cell populations. Our findings in DDR1
null mice may also encourage further research to identify
a potential role of DDR1 in human renal disease.
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